Liver Detoxification Clinical Trial Results Exciting, Says Retired Hematologist
Philadelphia, Pennsylvania, USA, September 26, 2008 – Dr. Jim Steigerwalt found a solution to his eight-year struggle to repair his damaged liver. Inspired by his own results, the retired hematologist ran clinical trials on the detoxification program he used...with amazing results.
Dr. Steigerwalt – also known as Dr. Jim – suffered from liver damage as a result of taking methotrexate, a medication prescribed to him in 2000. Conventional medical professionals told him there was little hope of reversing the damage to his liver.
“The damage resulted in liver enzyme readings double what they ought to have been,” says Dr. Jim. “But after the detoxification, I had my liver re-tested. I received a letter from Geisinger Health System in Danville, Pennsylvania stating that my levels have returned to normal.”
All the other participants in Dr. Jim’s clinical trials experienced positive results. One – who’d been rendered an invalid due to mood swings, extreme fatigue, and seizures – has not had a single seizure since the trial detoxification, and there has been a lessening of her other symptoms as well.
Another participant with high triglyceride levels, diabetes, and liver function problems experienced a twenty-one percent decrease in his triglyceride levels.
“These results are exciting,” says Dr. Jim. “We have all been helped tremendously by the liver detoxification program.
Dr. Jim has broad experience in the field of toxin-related illnesses, having worked globally in medical research capacities, and consulted with American physicians at Honnoman University, Johns Hopkins Hospital, University Medical Center at Princeton, and the University of Pennsylvania Health System. Dr. Jim is an expert witness for industrial hygiene cases, and acts as consultant to physicians at Lower Bucks (County) Hospital, and Geisinger Health System.
- Contact Information
- Joe Valley
- President and Founder
- Abbott Industries
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.